Last reviewed · How we verify

NCT03692962: DM-SR

Decision-making After Sleep Restriction

Completed NA Last updated 11 February 2021
What this trial tests

NA trial testing Sleep restriction in Sleep Restriction in 28 participants. Completed in 2 November 2020.

Timeline
1 September 2018
Primary endpoint
12 October 2020
2 November 2020

Quick facts

Lead sponsorChristian Baumann
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposebasic science
Enrollment28
Start date1 September 2018
Primary completion12 October 2020
Estimated completion2 November 2020
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Christian Baumann

Who can join

Adults 18 to 30, male only, with Sleep Restriction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to investigate whether enhancing sleep intensity locally in the prefrontal cortex (PFC) can counteract a deterioration of cognitive control and therefore the previously described increase in risk seeking during chronic sleep restriction. To this end, a controlled, counter-balanced study, consisting of two weeks of sleep restriction will be performed. During one of the sleep restriction weeks, sleep intensity in the PFC will be non-invasively enhanced by acoustic stimulation of slow waves during sleep.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sleep restriction

Trials testing the same drug.

Other recruiting trials for Sleep Restriction

Currently open trials in the same condition.

Other Christian Baumann trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03692962.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing